About: Accuray Incorporated engages in the design, development, and sale of radiosurgery and radiation therapy systems for the treatment of tumors throughout the body in the United States, Canada, Latin America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. It also provides the TomoTherapy platform, including the Radixact System, a tailored helical solution, which integrates radiation treatment planning, delivery, imaging, and data management; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, the company offers post-contract customer support, installation, training, and other professional services. It primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.
Sector: Healthcare
Industry: Medical Devices
Latest price: $0.14 (+6.49%)
ARAY NASDAQ Accuray Incorporated
Accuray Incorporated share price
Atividade de preço de ARAY
Último preço
$ 0,140
Variação (24h)
0,01 USD (6,87%)
Volume
1.22M
Volume (média 4 sem.)
-
Abertura
$ 0,13
Variação do dia
$ 0,13 - $ 0,14
Fechamento anterior
$ 0,13
Último negócio
29 Oct, 8:00 pm GMT+0
Atrasado
29 Oct, 8:00 pm GMT+0
ARAY price performance
Atrasado
29 Oct, 8:00 pm GMT+0
quote.marketSignals